Cargando…
The glycocalyx as a permeability barrier: basic science and clinical evidence
Preclinical studies in animals and human clinical trials question whether the endothelial glycocalyx layer is a clinically important permeability barrier. Glycocalyx breakdown products in plasma mostly originate from 99.6–99.8% of the endothelial surface not involved in transendothelial passage of w...
Autores principales: | Dull, Randal O., Hahn, Robert G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469578/ https://www.ncbi.nlm.nih.gov/pubmed/36096866 http://dx.doi.org/10.1186/s13054-022-04154-2 |
Ejemplares similares
-
The Glycocalyx and Pressure-Dependent Transcellular Albumin Transport
por: Dull, Randal O., et al.
Publicado: (2020) -
Hydrogen Sulfide Is a Novel Protector of the Retinal Glycocalyx and Endothelial Permeability Barrier
por: Allen, Claire L., et al.
Publicado: (2021) -
Interstitial washdown and vascular albumin refill during fluid infusion: novel kinetic analysis from three clinical trials
por: Hahn, Robert G., et al.
Publicado: (2021) -
Xenotransplantation—A Basic Science Perspective
por: Cooper, David K.C., et al.
Publicado: (2023) -
Hemodilution causes glycocalyx shedding without affecting vascular endothelial barrier permeability in rats
por: Ergin, Bülent, et al.
Publicado: (2020)